Evidence map›Paper›PMID 33064090›Full record

ArticleJournal of participatory medicine2020

Patient and Family Participation in Clinical Guidelines Development: The Cystic Fibrosis Foundation Experience.

Sarah E Hempstead, Kelsey Fredkin, Cade Hovater, Edward T Naureckas

Abstract read
In one paragraph

Article in Journal of participatory medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Transforming Care Models in Cystic Fibrosis: A Review.Healthcare (Basel, Switzerland) · 2025
    Review
  3. A Qualitative Study to Improve How We Partner With Patients and Families in Healthcare Improvement Collaboratives.Health expectations : an international journal of public participation in health care and health policy · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sarah E Hempstead *Cystic Fibrosis Foundation, Bethesda, MD, United States.ORCID https://orcid.org/0000-0003-3856-025X
Kelsey FredkinCystic Fibrosis Foundation, Bethesda, MD, United States.ORCID https://orcid.org/0000-0003-4297-3807
Cade HovaterCommunity Advisor to the Cystic Fibrosis Foundation, Bethesda, MD, United States.ORCID https://orcid.org/0000-0003-3485-1789
Edward T NaureckasDepartment of Pulmonary Medicine, University of Chicago, Chicago, IL, United States.ORCID https://orcid.org/0000-0002-3171-8176

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patient and family participation in guideline development is neither standardized nor uniformly accepted in the guideline development community, despite the 2011 Institute of Medicine's Guidelines We Can Trust and the Guideline International Network's GIN-Public Toolkit recommendations. The Cystic Fibrosis Foundation has included patients and/or family members directly in guideline development since 2004. Over time, various strategies for increasing patient and family member participation have been implemented. Surveys of recent patient/family and clinical guidelines committee members have shown that inclusion of individuals with cystic fibrosis and their family members on guidelines committees has provided insight otherwise invisible to clinicians.

Indexed as

cystic fibrosisguidelinespatient engagementpatient participation

Identifiers

PMID33064090
PMCPMC7434055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.